---
id: PULM008
specialty: pulmonology
topic: pulmonary-hypertension
difficulty: hard
tags: [respiratory, chronicCare, cardiovascular, copilotO1]
created: 2025-01-02
lastUpdated: 2025-01-02
---

# Pulmonary Hypertension Management

## Question
A 42-year-old woman with dyspnea on exertion undergoes right heart catheterization confirming pulmonary arterial hypertension (PAH). Which specific therapy is most appropriate?

## Options
| Option | Description                                                     |
|--------|-----------------------------------------------------------------|
| A)     | High-dose diuretics + vasopressors                             |
| B)     | Prostacyclin analog (epoprostenol) infusion                    |
| C)     | Beta-2 agonists + inhaled corticosteroids                      |
| D)     | Empiric antibiotics + chest physiotherapy                      |
| E)     | Oral nitrate plus digoxin                                      |

<details>
<summary>View Answer</summary>

## Correct Answer
B

## Explanation
1. PAH often requires targeted vasodilator therapy: prostanoids, PDE5 inhibitors, or endothelin receptor antagonists.  
2. Epoprostenol improves outcomes in severe PAH.  
3. Diuretics can help volume overload but are not definitive.  

## References
- CHEST 2022: "Pulmonary Arterial Hypertension Update"
- NEJM 2021: "Advances in PAH Treatment"
</details>